Fox Chase Cancer Center Announces New Immunotherapy Clinical Trial for Breast Cancer Patients
PHILADELPHIA (May 15, 2017) – Medical oncologists Lori Goldstein, MD, and Elias Obeid, MD, MPH, are opening a phase 2 immunotherapy clinical trial for newly diagnosed, locally recurrent, or metastatic HER2-overexpressing breast cancer.